Showing results (101-110 of 208) with videos related to

Sort By:
Pageof 21
International Journal of Cardiology|April 17, 2016
Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trialsAntoine Hollebecque, Emilie Lanoy, Frederic Troallen, et al.
Leukemia & Lymphoma|November 23, 2017
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experienceKhalil Saleh, Alina Danu, Serge Koscielny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2020
A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) plus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) with Poor Prognosis FeaturesClémentine Sarkozy, Franck Morschhauser, Sydney Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2018
Organisational factors influencing early clinical trials enrollment: Gustave Roussy experienceSylvain Besle, Emilien Schultz, Antoine Hollebecque, et al.
Haematologica|August 30, 2023
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa studyEnrique M Ocio, Yvonne A Efebera, Roman Hájek, et al.
Hemasphere|October 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphomaMats Jerkeman, Igor Aurer, Elias Campo, et al.
European Journal of Haematology|September 21, 2024
Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023Matteo Guerra, Emily Alouani, Thomas Hueso, et al.
Blood|May 30, 2015
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphomaMarie-Hélène Delfau-Larue, Wolfram Klapper, Françoise Berger, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancersRadhia M'kacher, Annelise Bennaceur-Griscelli, Theodore Girinsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2021
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaVincent Ribrag, Seung Tae Lee, David Rizzieri, et al.
Pageof 21